Chemotherapy drugs cells anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells HT29 Cells MCF-7 Cells Cell Line

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases50

Neoplasms Radiation Injuries Breast Neoplasms Ovarian Neoplasms Lung Neoplasms Radiation Pneumonitis Radiation Injuries, Experimental Neoplasm Recurrence, Local Adenocarcinoma Neoplasms, Radiation-Induced Brain Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis Colonic Neoplasms Carcinoma, Squamous Cell Colorectal Neoplasms Liver Neoplasms Head and Neck Neoplasms Hodgkin Disease Lymphoma, Non-Hodgkin Osteosarcoma Carcinoma Bone Neoplasms Testicular Neoplasms Vomiting Neutropenia Nausea Neoplasms, Experimental Stomach Neoplasms Lymphoma Acute Radiation Syndrome Pancreatic Neoplasms Glioma Glioblastoma Neoplasms, Germ Cell and Embryonal Leukopenia Lymphatic Metastasis Disease Progression Recurrence Precursor Cell Lymphoblastic Leukemia-Lymphoma Sarcoma Melanoma Leukemia, Radiation-Induced Peritoneal Neoplasms Radiodermatitis Leukemia Germinoma Leukemia P388 Neoplasms, Second Primary Stomatitis

Chemicals and Drugs86

Antineoplastic Agents Cisplatin Doxorubicin Etoposide Antineoplastic Agents, Phytogenic Paclitaxel Fluorouracil Cyclophosphamide Antibiotics, Antineoplastic Vinblastine Camptothecin Methotrexate Antimetabolites, Antineoplastic Organoplatinum Compounds Carboplatin Bleomycin Taxoids Antineoplastic Agents, Alkylating Drug Carriers Deoxycytidine Radiation-Sensitizing Agents P-Glycoprotein Daunorubicin Anthracyclines Mitomycin Mitoxantrone Ellipticines Platinum Ifosfamide Cytarabine Dacarbazine Platinum Compounds Tumor Suppressor Protein p53 Radiation-Protective Agents Prodrugs DNA Topoisomerases, Type II Carmustine Enzyme Inhibitors Tumor Markers, Biological Melphalan Topoisomerase I Inhibitors Proto-Oncogene Proteins c-bcl-2 Neoplasm Proteins Antibodies, Monoclonal Nimustine Tegafur Antibodies, Monoclonal, Humanized Plant Extracts Angiogenesis Inhibitors Caspases Lomustine Adjuvants, Pharmaceutic Chlorambucil Multidrug Resistance-Associated Proteins Nanocapsules Floxuridine Caspase 3 DNA Teniposide Cobalt Radioisotopes Topotecan Razoxane Drugs, Investigational Granulocyte Colony-Stimulating Factor Antiemetics Thiotepa Topoisomerase II Inhibitors DNA-Binding Proteins Mitomycins RNA, Small Interfering ATP-Binding Cassette Transporters Protein Kinase Inhibitors DNA Adducts RNA, Messenger Topoisomerase Inhibitors Quinazolines DNA, Neoplasm Intercalating Agents Bridged Compounds Liposomes Radiopharmaceuticals Tubulin Modulators Receptor, erbB-2 Pyrazines Xanthones DNA Topoisomerases, Type I

Analytical, Diagnostic and Therapeutic Techniques and Equipment69

Antineoplastic Combined Chemotherapy Protocols Drug Screening Assays, Antitumor Chemotherapy, Adjuvant Radiation Dosage Drug Delivery Systems Combined Modality Therapy Dose-Response Relationship, Radiation Treatment Outcome Radiation Monitoring Disease-Free Survival Radiotherapy Neoadjuvant Therapy Neoplasm Staging Survival Analysis Prognosis Drug Administration Schedule Survival Rate Xenograft Model Antitumor Assays Radiotherapy Dosage Drug Carriers Radiation Injuries, Experimental Radiotherapy, Adjuvant Induction Chemotherapy Clinical Trials as Topic Inhibitory Concentration 50 Follow-Up Studies Radiometry Drug Design Salvage Therapy Neoplasm Transplantation Dose Fractionation Radiotherapy, Conformal Chemotherapy, Cancer, Regional Perfusion Drug Evaluation, Preclinical Molecular Targeted Therapy Hyperthermia, Induced Prospective Studies Tumor Burden Neoplasms, Experimental Transplantation, Autologous Chemoradiotherapy Kaplan-Meier Estimate Cranial Irradiation Flow Cytometry Radiotherapy, Intensity-Modulated Tomography, X-Ray Computed Nanocapsules Transplantation, Heterologous Drug Discovery Blotting, Western Brachytherapy Palliative Care Models, Biological Infusions, Intra-Arterial Infusions, Intravenous Drug Therapy Clinical Trials, Phase I as Topic Immunohistochemistry Radiation Hybrid Mapping Administration, Oral Hematopoietic Stem Cell Transplantation Randomized Controlled Trials as Topic Actuarial Analysis Whole-Body Irradiation Feasibility Studies Drug Evaluation Tumor Stem Cell Assay Radiotherapy, High-Energy Positron-Emission Tomography

Phenomena and Processes35

Drug Resistance, Neoplasm Radiation Dosage Radiation, Ionizing Apoptosis Cell Survival Dose-Response Relationship, Radiation Radiation Tolerance Radiation Dose-Response Relationship, Drug Cell Proliferation Gene Expression Regulation, Neoplastic Time Factors Gamma Rays Cosmic Radiation DNA Damage Drug Resistance, Multiple Drug Synergism Background Radiation Inhibitory Concentration 50 Ultraviolet Rays Cell Cycle Molecular Structure Radiation Effects DNA Repair Signal Transduction Drug Resistance Cell Division Cell Death X-Rays Genes, MDR DNA Adducts Mutation Structure-Activity Relationship Cell Cycle Checkpoints Down-Regulation

Disciplines and Occupations8

Radiation Oncology Drug Design Nanomedicine Drug Discovery Medical Oncology Immunohistochemistry Radiobiology Pharmacogenetics

Technology, Industry, Agriculture4

Nanoparticles Nanomedicine Nanocapsules Liposomes

Information Science3

Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated

Health Care26

Employer Health Costs Radiation Dosage Prescription Fees Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Treatment Outcome Radiation Monitoring Disease-Free Survival Survival Analysis Survival Rate Cosmic Radiation Radiation Injuries, Experimental Clinical Trials as Topic Ultraviolet Rays Follow-Up Studies Radiation Effects Prospective Studies Kaplan-Meier Estimate Acute Radiation Syndrome Palliative Care Clinical Trials, Phase I as Topic Radioactive Hazard Release Randomized Controlled Trials as Topic Actuarial Analysis Feasibility Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Cisplatin Doxorubicin Employer Health Costs Cell Line, Tumor Neoplasms Drug Resistance, Neoplasm Drug Screening Assays, Antitumor Etoposide Chemotherapy, Adjuvant Antineoplastic Agents, Phytogenic Radiation Dosage Radiation, Ionizing Prescription Fees Drug Delivery Systems Paclitaxel Apoptosis Cell Survival Radiation Injuries Breast Neoplasms Combined Modality Therapy Dose-Response Relationship, Radiation Radiation Tolerance Fluorouracil Tumor Cells, Cultured Radiation Dose-Response Relationship, Drug Ovarian Neoplasms Cell Proliferation Radiation Protection Treatment Outcome Radiation Monitoring Cyclophosphamide Gene Expression Regulation, Neoplastic Antibiotics, Antineoplastic Disease-Free Survival Radiotherapy Neoadjuvant Therapy Lung Neoplasms Neoplasm Staging Survival Analysis Radiation Oncology Vinblastine Camptothecin Prognosis Methotrexate Antimetabolites, Antineoplastic Drug Administration Schedule Organoplatinum Compounds Survival Rate Carboplatin Xenograft Model Antitumor Assays Radiotherapy Dosage Bleomycin Mice, Nude Taxoids Antineoplastic Agents, Alkylating Time Factors Gamma Rays Drug Carriers Radiation Pneumonitis Cosmic Radiation Radiation Injuries, Experimental DNA Damage Neoplasm Recurrence, Local Deoxycytidine Radiation-Sensitizing Agents Adenocarcinoma P-Glycoprotein Drug Resistance, Multiple Neoplasms, Radiation-Induced Daunorubicin Anthracyclines Radiotherapy, Adjuvant Brain Neoplasms Carcinoma, Non-Small-Cell Lung Mitomycin Mitoxantrone Drug Synergism Induction Chemotherapy Clinical Trials as Topic Ellipticines Platinum Background Radiation Neoplasm Metastasis Ifosfamide Inhibitory Concentration 50 Cytarabine Ultraviolet Rays Follow-Up Studies Dacarbazine Colonic Neoplasms Radiometry Cell Cycle Carcinoma, Squamous Cell Platinum Compounds Molecular Structure Drug Design Tumor Suppressor Protein p53

No FAQ available that match "chemotherapy drugs cells anticancer drugs or radiation"